Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

During the Trading Day
10.20 +0.14 / +1.39%
As of 4:14pm ET
Day’s Change
During After-Hours   Switch to standard view »
10.20 0.00 / 0.00%
 
Volume: 24.5K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues34.2M48.9M47.8M102.8M
 
 
 
 
 
Depreciation And Amortization5.3M3.7M2.6M3.2M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses109.8M138.0M164.9M165.8M
 
 
 
 
 
Research And Development100.6M125.9M146.3M138.5M
 
 
 
 
 
Total Operating Expenses115.1M141.7M167.5M169.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-80.9M-92.7M-119.7M-66.3M
 
 
 
 
 
Extraordinary Charge-864.0K0.00-800.0K0.00
 
 
 
Interest Expense On Debt13.0K553.0K10.9M18.2M
 
 
 
 
 
Other Expenses2.0M1.4M627.0K813.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-79.7M-91.8M-130.7M-83.6M
 
 
 
 
 
Minority Interest-453.0K-477.0K-240.0K-268.0K
 
 
 
 
 
Net Income-79.2M-91.3M-130.9M-83.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.3M72.8M98.9M104.4M
 
 
 
 
 
Shares To Calculate EPS Diluted11.3M72.8M98.9M104.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$7.67-$1.28-$1.32-$0.80
 
 
 
 
 
EPS Diluted-$6.98-$1.25-$1.32-$0.80